| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
GNAS complex locus | 0.420 | 0.885 | 0.68 |
|
group | 0.130 | None | 1.000 | 1 | 1 | 2014 | 2019 | ||||||||
|
LDL receptor related protein 1 | 0.482 | 0.769 | 1.00 |
|
group | 0.110 | None | 1.000 | 2 | 2 | 2007 | 2019 | ||||||||
|
leucine rich repeats and immunoglobulin like domains 1 | 0.601 | 0.538 | 3.5E-02 |
|
group | 0.110 | None | 1.000 | 2 | 1 | 2011 | 2019 | ||||||||
|
fibroblast growth factor receptor 2 | 0.380 | 0.808 | 1.00 |
|
group | 0.110 | None | 1.000 | 1 | 1 | 2005 | 2016 | ||||||||
|
limbic system associated membrane protein | 0.558 | 0.654 | 0.99 |
|
group | 0.110 | None | 1.000 | 1 | 1 | 2001 | 2015 | ||||||||
|
potassium voltage-gated channel subfamily H member 1 | 0.542 | 0.731 | 0.55 |
|
group | 0.110 | None | 1.000 | 1 | 1 | 2007 | 2016 | ||||||||
|
T-box transcription factor 3 | 0.525 | 0.769 | 0.99 |
|
group | 0.110 | None | 1.000 | 1 | 1 | 2013 | 2013 | ||||||||
|
cadherin 3 | 0.560 | 0.615 | 2.8E-10 |
|
group | 0.110 | None | 1.000 | 1 | 1 | 2008 | 2019 | ||||||||
|
endothelin 1 | 0.380 | 0.846 | 0.46 |
|
group | 0.110 | None | 1.000 | 1 | 1 | 2001 | 2019 | ||||||||
|
myeloid zinc finger 1 | 0.617 | 0.577 | 1.1E-10 |
|
group | 0.110 | None | 1.000 | 1 | 1 | 2010 | 2019 | ||||||||
|
HNF1 homeobox B | 0.473 | 0.808 | 1.00 |
|
group | 0.110 | None | 1.000 | 1 | 1 | 2015 | 2016 | ||||||||
|
POU class 5 homeobox 1B | 0.670 | 0.346 | 2.9E-04 |
|
group | 0.100 | None | 1.000 | 18 | 5 | 2007 | 2019 | ||||||||
|
prostate cancer associated transcript 1 | 0.575 | 0.615 |
|
group | 0.100 | None | 1.000 | 18 | 5 | 2007 | 2019 | |||||||||
|
cancer susceptibility 8 | 0.670 | 0.462 |
|
group | 0.100 | None | 1.000 | 18 | 5 | 2007 | 2019 | |||||||||
|
colon cancer associated transcript 2 | 0.621 | 0.615 |
|
group | 0.100 | None | 1.000 | 14 | 3 | 2007 | 2019 | |||||||||
|
colorectal cancer associated 1 | 0.780 | 0.154 |
|
group | 0.100 | None | 1.000 | 9 | 2 | 2008 | 2019 | |||||||||
|
colorectal cancer associated 2 | 0.769 | 0.154 | 0.75 |
|
group | 0.100 | None | 1.000 | 9 | 2 | 2008 | 2019 | ||||||||
|
CCND2 antisense RNA 1 | 0.760 | 0.154 |
|
group | 0.100 | None | 1.000 | 7 | 4 | 2013 | 2019 | |||||||||
|
chromosome 5 open reading frame 66 | 0.760 | 0.154 | 5.3E-04 |
|
group | 0.100 | None | 1.000 | 7 | 4 | 2013 | 2019 | ||||||||
|
ZMIZ1 antisense RNA 1 | 0.780 | 0.115 |
|
group | 0.100 | None | 1.000 | 6 | 1 | 2014 | 2019 | |||||||||
|
ataxin 2 | 0.482 | 0.808 | 0.85 |
|
group | 0.100 | None | 1.000 | 6 | 2 | 2015 | 2019 | ||||||||
|
transmembrane protein 258 | 0.644 | 0.654 | 1.9E-03 |
|
group | 0.100 | None | 1.000 | 5 | 2 | 2014 | 2019 | ||||||||
|
myelin regulatory factor | 0.584 | 0.731 | 1.00 |
|
group | 0.100 | None | 1.000 | 5 | 2 | 2014 | 2019 | ||||||||
|
laminin subunit gamma 1 | 0.628 | 0.654 | 1.00 |
|
group | 0.100 | None | 1.000 | 4 | 3 | 2013 | 2019 | ||||||||
|
PNKD metallo-beta-lactamase domain containing | 0.615 | 0.615 | 4.1E-08 |
|
group | 0.100 | None | 1.000 | 4 | 3 | 2018 | 2019 |